pharma news today glp-1 today India's fast-growing weight-loss drug market is showing signs of moderation after a sharp surge in recent months. New data reveals that sales growth of semaglutide and therapies slowed pharma news today obesity drugs

FeelGood GLP-1 2026 Research Explores Brand-Stated $149/Month Telehealth Access, Compounded Medication Disclosures, and Buyer Questions Why This Review Exists Right Now - and Why Timing Matters for GLP-1 Buyers in 2026 FDA has publicly identified concerns involving unapproved and compounded GLP-1 products, including dosing errors, improper storage during shipping, fraudulent compounded products, adverse-event reports, semaglutide salt forms, and illegal online sales

The site is updated occasionally, but may not reflect the most up-to-date information

10.3390/diagnostics15030396 Diagnostics

Accessed July 8, 2025